Dosimetric impact of interfraction catheter movement and organ motion on MRI/CT guided HDR interstitial brachytherapy for gynecologic cancer.

PURPOSE To determine the dosimetric impact of catheter movement for MRI/CT image guided high dose rate (HDR) interstitial brachytherapy (ISBT) for gynecologic cancers. MATERIALS AND METHODS Ten patients were treated with HDR ISBT. The CTV and organs at risk were contoured using a postimplant MRI and CT. 5 fractions were delivered twice daily on 3 consecutive days. The first fraction was delivered on day 1 (d1), fraction 2-3 on d2 and fraction 4-5 on d3. MRI/CT was acquired prior to the second and fourth fractions. Four scenarios were modeled. (1) The d1 plan was applied to the d2 and d3 CT, using the updated catheter positions. (2) Replanning was performed for d2 and d3. (3) We applied the dwell positions/times from the d2 replan over the d3 CT and compared with a d3 CT replan. (4) Based on daily MRI, target volumes were recontoured and replanned. Dosimetry was analyzed for each plan and compared to the d1 dose distribution. RESULTS (1) When using the d1 plan on the d2 and d3 CT with the updated catheter positions, the mean CTV D90 was reduced from 93.4% on d1 to 89.3% (p=0.08) on d2 and to 87.7% (p=0.005) on d3. (2) Replanning on d2 and d3 compensated for catheter movement, mean CTV D90 of 95.4% on d2 and 94.6% (p=0.36) on d3. (3) When compared to the replan of d2 applied on the d3 CT vs the d3 replan, there was no significant difference in coverage, mean CTV D90 of 90.9% (p=0.09). (4) Reoptimization based on daily MRI, significantly improved the CTV coverage for each day. The mean D2cc for the rectum was significantly higher with model 1 vs model 3 59.1±4.7 vs 60.9±4.8 (p=0.04) Gy EQD2. There were no significant differences in D2cc of bladder and sigmoid between models. CONCLUSIONS Interfraction dosimetric changes significantly decreased the CTV coverage of the third day. Rather than replanning on each day, replanning on the day 2 CT before the second or third fraction would give an optimal solution that would compensate for interfraction catheter displacement.

[1]  J. Dimopoulos,et al.  Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  B. Skipper,et al.  The Syed-Neblett interstitial template in locally advanced gynecological malignancies. , 1983, International journal of radiation oncology, biology, physics.

[3]  J. Pouliot,et al.  Measurement of craniocaudal catheter displacement between fractions in computed tomography–based high dose rate brachytherapy of prostate cancer , 2007, Journal of applied clinical medical physics.

[4]  H. Yamazaki,et al.  Daily CT measurement of needle applicator displacement during multifractionated high-dose-rate interstitial brachytherapy for postoperative recurrent uterine cancer. , 2012, Journal of radiation research.

[5]  Kazuya Honda,et al.  Daily computed tomography measurement of needle applicator displacement during high-dose-rate interstitial brachytherapy for previously untreated uterine cervical cancer. , 2011, Brachytherapy.

[6]  A. Syed,et al.  Treatment of extensive carcinoma of the cervix with the "transperineal parametrial butterfly": a prelimary report on the revival of Waterman's approach. , 1978, International journal of radiation oncology, biology, physics.

[7]  Silvia D. Chang,et al.  Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. , 2004, International journal of radiation oncology, biology, physics.

[8]  Umesh Mahantshetty,et al.  Quality assurance of multifractionated pelvic interstitial brachytherapy for postoperative recurrences of cervical cancers: a prospective study. , 2012, International journal of radiation oncology, biology, physics.

[9]  S J Damore,et al.  Needle displacement during HDR brachytherapy in the treatment of prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[10]  P. Hoskin,et al.  High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  D. Heron,et al.  High-dose-rate interstitial brachytherapy for gynecologic malignancies. , 2006, Brachytherapy.

[12]  J. Pouliot,et al.  Dosimetric impact of interfraction catheter movement in high-dose rate prostate brachytherapy. , 2011, International journal of radiation oncology, biology, physics.